Central lab

OPTUS pharmaceutical R&D is developing various types of new drugs through focused studies on ophthalmics and investing efforts and time for development of preservative free eye drops, dry eye preparations, glaucoma treatment and anti-infective eye preparations. In addition, with “Global Open Innovation” in mind, we are making constant challenges to move forward and be recognized as a professional, global ophthalmic specialist.

PIPELINE

Category	project	indications	steps
Global	Travo Vision Sine Eye Drops(UD)	Glaucoma	Approved (in EU markets)
	OP11009	Glaucoma	Clinical study completed
	OP11010	Glaucoma	Process development
Domestic	OP11001	Glaucoma	Process development
	OP11002	Anti-inflammatory	Process development
	OP11003	Anti-inflammatory	Process development
	Allervid Eye Drops 0.2%(UD)	Anti-allergy preparations	Approved
	Diqua Free Eye Drops(UD)	Dry eye preparations	Approved
	Combi Free Eye Drops(UD)	Glaucoma	Approved
	Ouesoo Trehalose Eye Drops(UD)	Dry eye preparations	Approved
	Dr.Fresh F Eye Drop(UD)	Dry eye preparations	Approved
	Allervid Eye Drops 0.7%(UD)	Anti-allergy preparations	Approved

Development strategies

Development Strategy

New technology

Developing preservative-free formulation,
liquid form stabilization,
poorly soluble drug formulation improvement

Exploring new products

New generics,
New drugs,
IMD drugs,
Combination formulations

Open Innovation

Tech alliance,
Global development through license in/out

Personal information collection and usage agreement

Personal information collection and usage agreement

Collected personal information

We collect personal information for consultation and service application etc. as follows.

- Collected personal info : name, e-mail

- Method : when writing a post in the website (customer inquiry etc.)
Personal info collection and purpose
We use the collected information for the following purposes.

- Customer inquiry, complaint handling, identification etc.

Personal information retention and period

Once the purpose of collecting the information is achieved, the relevant information will be destroyed immediately. However, the following type of information will be kept for a period of time for the below reasons.

- Type of information : name, contact information, e-mail, address

- Reason : customer protection and data management

- Retention period : 1 year

Customer complaint and arbitration handling related records : 3 years (according to Act on the customer protection in electronic commerce)
I agree to the personal information collection and usage agreement.

Submit

Central lab

Central lab

PIPELINE

Development strategies

Personal information collection and usage agreement

Unauthorized collection of e-mails